Therapies in the fight against Covid-19

Authors

  • Jihane KHAMLICH Environmental health laboratory, Institut Pasteur du Maroc, 1, Place Louis Pasteur 20360 Casablanca, Morocco Biology of human pathologies laboratory, Genomics center of human pathologies(GENOPATH), Faculty of sciences, Rabat, Marocco
  • Imane DOUIYEH Environmental health laboratory, Institut Pasteur du Maroc, 1, Place Louis Pasteur 20360 Casablanca, Morocco Biology of human pathologies laboratory, Genomics center of human pathologies(GENOPATH), Faculty of sciences, Rabat, Marocco
  • Houda EL ALAMI Environmental health laboratory, Institut Pasteur du Maroc, 1, Place Louis Pasteur 20360 Casablanca, Morocco.
  • Islam EL JADDAOUI Biology of human pathologies laboratory, Genomics center of human pathologies(GENOPATH), Faculty of sciences, Rabat, Marocco
  • Ines NEFLA University Mohammed VI of Health Sciences, Casablanca, Morocco
  • Lahcen WAKRIM Laboratoire of Immunovirology, Institut Pasteur du Maroc
  • Hicham EL FAZAZI CHU Ibn Rochd –Faculty of Medicine and pharmacy, Casablanca, Morocco
  • Mohammed TIMINOUNI Molecular Bacteriology Laboratory, Institut Pasteur du Maroc
  • Youssef BAKRI Biology of human pathologies laboratory, Genomics center of human pathologies(GENOPATH), Faculty of sciences, Rabat, Marocco
  • Hassan GHAZAL National Center for Scientific Technical Research (CNRST), Rabat 10102, Morocco. University Mohammed VI of Health Sciences, Casablanca, Morocco.
  • Salsabil HAMDI Environmental health laboratory, Institut Pasteur du Maroc, 1, Place Louis Pasteur 20360 Casablanca, Morocco

DOI:

https://doi.org/10.34874/PRSM.mjph-vol1iss1.24191

Keywords:

Coronavirus, Covid-19, SARS-CoV-2, Treatment, Drugs, Medicine, Therapy

Abstract

SARS-Cov-2 Coronavirus is a new emerging virus causing the COVID-19, a respiratory disease outbreak that started in China in December 2019. On January 30, 2020, the World Health Organization has declared this to be a public health emergency of international concern. By September 2020, COVID-19 has affected more than 33 millionin 210 countries and territories worldwide. In this review, we present an overview of the drugs and medicines to combat COVID-19 currently in the clinical trial. We summarize the challenges facing, and opportunities for the discovery of new therapies in this emergency situation.

Downloads

Published

25-12-2020

Issue

Vol. 1 No. 1 (2020): Special issue on emerging COVID-19

Section

Articles